Follow-up of the first patients with a totally subcutaneous ICD in Germany from implantation till battery depletion
- PMID: 29948287
- DOI: 10.1007/s00392-018-1296-1
Follow-up of the first patients with a totally subcutaneous ICD in Germany from implantation till battery depletion
Abstract
Background: The subcutaneous ICD is a promising treatment option in patients at risk for sudden cardiac death. Approved in 2009, the first S-ICD® in Germany was implanted in June 2010. Although large prospective registry studies have shown safety and efficacy of the system, there is a lack of long-term data with regard to battery longevity of the S-ICD®. Therefore, we report follow-up of our first initial S-ICD® cases from implantation till battery depletion.
Materials and methods: All S-ICD® patients with device replacement for battery depletion in our large single-center S-ICD® registry were included in this study. Baseline characteristics, appropriate and inappropriate shocks, and complications were documented in a median follow-up of 75.9 ± 6.8 months.
Results: Twenty-eight patients with S-ICD® systems were included in this study. Of these patients, 21 were male and 7 were female, with an overall mean age of 41.9 ± 12.6 years. Primary prevention of sudden cardiac death was the indication in 19 patients (67.9%). Ventricular tachycardia was adequately terminated in two patients (7.1%). In 7 patients, non-sustained ventricular arrhythmias were not treated. A total of three inappropriate shocks occurred in three patients (10.7%). Mean time from implantation till battery depletion was 65.8 ± 8.1 months. Only one patient presented premature elective replacement criteria because of rapid battery depletion. No lead-related complication occurred during follow-up and no complications were seen regarding device replacement. In one patient (3.6%), the system was explanted without replacement due to patient's preference.
Conclusion: The estimated battery longevity of S-ICD® of about 5 years was reached in all but one patient. Compared to larger S-ICD® registry studies, frequency of inappropriate shocks was relatively high in the initial S-ICD® cases. Both technological improvement as well as programming and operators' experience have led to a reduction of complications. Replacement of the S-ICD® seems to be a safe and effective procedure.
Keywords: Battery depletion; Device replacement; Longevity; Subcutaneous ICD.
Similar articles
-
Performance of the entirely subcutaneous ICD in borderline indications.Clin Res Cardiol. 2020 Jun;109(6):694-699. doi: 10.1007/s00392-019-01558-z. Epub 2019 Oct 4. Clin Res Cardiol. 2020. PMID: 31586219
-
Effectiveness of subcutaneous implantable cardioverter-defibrillators and determinants of inappropriate shock delivery.Int J Cardiol. 2017 Apr 1;232:176-180. doi: 10.1016/j.ijcard.2017.01.034. Epub 2017 Jan 5. Int J Cardiol. 2017. PMID: 28082086
-
Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.JACC Clin Electrophysiol. 2017 Dec 26;3(13):1499-1506. doi: 10.1016/j.jacep.2017.08.017. Epub 2017 Nov 6. JACC Clin Electrophysiol. 2017. PMID: 29759830
-
[The subcutaneous cardioverter-defibrillator: When less is more].Herzschrittmacherther Elektrophysiol. 2015 Jun;26(2):123-8. doi: 10.1007/s00399-015-0378-2. Epub 2015 Jun 10. Herzschrittmacherther Elektrophysiol. 2015. PMID: 26058997 Review. German.
-
Long-term follow-up of implantable cardioverter-defibrillators in Short QT syndrome.Clin Res Cardiol. 2019 Oct;108(10):1140-1146. doi: 10.1007/s00392-019-01449-3. Epub 2019 Mar 16. Clin Res Cardiol. 2019. PMID: 30879093 Review.
Cited by
-
[Subcutaneous implantable cardioverter-defibrillator : Current status and perspectives].Herzschrittmacherther Elektrophysiol. 2018 Dec;29(4):349-354. doi: 10.1007/s00399-018-0593-8. Epub 2018 Oct 10. Herzschrittmacherther Elektrophysiol. 2018. PMID: 30306303 Review. German.
-
Prognostic impact of chronic kidney disease and renal replacement therapy in ventricular tachyarrhythmias and aborted cardiac arrest.Clin Res Cardiol. 2019 Jun;108(6):669-682. doi: 10.1007/s00392-018-1396-y. Epub 2018 Dec 21. Clin Res Cardiol. 2019. PMID: 30578436
-
[History of the implantable cardioverter-defibrillator in Germany].Herzschrittmacherther Elektrophysiol. 2024 Mar;35(Suppl 1):55-67. doi: 10.1007/s00399-024-01001-5. Epub 2024 Feb 29. Herzschrittmacherther Elektrophysiol. 2024. PMID: 38421401 Free PMC article. Review. German.
-
Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Systematic Review and Meta-Analysis of Randomized Trials and Propensity Score-Matched Studies.J Am Heart Assoc. 2022 Jun 7;11(11):e024756. doi: 10.1161/JAHA.121.024756. Epub 2022 Jun 3. J Am Heart Assoc. 2022. PMID: 35656975 Free PMC article.
-
Multicentre early experience with totally subcutaneous cardioverter-defibrillators in Poland.Arch Med Sci. 2019 May 21;16(4):764-771. doi: 10.5114/aoms.2019.83817. eCollection 2020. Arch Med Sci. 2019. PMID: 32542076 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical